IceCure Medical Ltd (ICCM) can make a big difference with a little luck

IceCure Medical Ltd (NASDAQ: ICCM) stock jumped 1.57% on Monday to $1.29 against a previous-day closing price of $1.27. With 0.61 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.51 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.3200 whereas the lowest price it dropped to was $1.2800. The 52-week range on ICCM shows that it touched its highest point at $4.73 and its lowest point at $0.75 during that stretch.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ICCM was up-trending over the past week, with a rise of 5.74%, but this was down by -50.38% over a month. Three-month performance surged to 0.78% while six-month performance fell -25.43%. The stock lost -48.19% in the past year, while it has lost -16.77% so far this year. A look at the trailing 12-month EPS for ICCM yields -0.40 with Next year EPS estimates of -0.36. For the next quarter, that number is -0.11. This implies an EPS growth rate of -28.60% for this year and 20.00% for next year.


Float and Shares Shorts:

At present, 45.62 million ICCM shares are outstanding with a float of 15.57 million shares on hand for trading. On Oct 13, 2022, short shares totaled 91280.0, which was 0.25% higher than short shares on Sep 14, 2022. In addition to Mr. Eyal Shamir as the firm’s CEO & Director, Mr. Ronen Tsimerman CPA serves as its CFO & COO.

Institutional Ownership:

Through their ownership of 8.95% of ICCM’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of ICCM, in contrast to — held by mutual funds. Shares owned by individuals account for –. With a 0.41% stake in ICCM, the SPDR Portfolio Developed World ex is the largest stakeholder. A total of 186,746 shares are owned by the mutual fund manager. The Tachlit SAL, which owns about 0.07% of ICCM stock, is the second-largest Mutual Fund holder. It holds 29,822 shares valued at 45335.0. Tachlit SAL holds 0.06% of the stake in ICCM, owning 25,308 shares worth 38473.0.


Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ICCM since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ICCM analysts setting a high price target of $4.58 and a low target of $4.00, the average target price over the next 12 months is $4.28. Based on these targets, ICCM could surge 255.04% to reach the target high and rise by 210.08% to reach the target low. Reaching the average price target will result in a growth of 231.78% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. ICCM will report FY 2022 earnings on 01/29/2024. Analysts have provided yearly estimates in a range of -$0.42 being high and -$0.46 being low. For ICCM, this leads to a yearly average estimate of -$0.45. Based on analyst estimates, the high estimate for the next quarter is -$0.11 and the low estimate is -$0.11. The average estimate for the next quarter is thus -$0.11.

Leave a Comment

Your email address will not be published. Required fields are marked *